Efficacy and Safety of Spironolactone in Pediatric Hemodialysis Patients With Anemia.
NCT07715318
Anemia, Chronic Disease
View Trial DetailsNCT Number: NCT06493435
Perioperative anemia is associated with higher risk of red blood cell transfusion, higher rates of morbimortality and lower quality of postoperative recovery. In a context of focussing on higher quality management and improved recovery after surgery, development of Patient Blood management has increased. This study aim to assess PBM protocole in a postoperative context of gynaecological surgery, by comparing indicators at two time periods: 2 and 8 months after establishment of PBM protocol.
Trial opening soon.
Get Notified18 year and older
Female
Observational
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: at 2 and 8 months after establishment of PBM protocol
preoperative Hb<13g/dL
Time frame: at 2 and 8 months after establishment of PBM protocol
Hb<13 g/dL
Time frame: at 2 and 8 months after establishment of PBM protocol
number and rate of blood analyses
Time frame: at 2 and 8 months after establishment of PBM protocol
blood ferritin level <100 ng/mL
Time frame: at 2 and 8 months after establishment of PBM protocol
rate of iron prescription
Time frame: at 2 and 8 months after establishment of PBM protocol
rate of persistent pre operative anemia after iron treatment
Time frame: at 2 and 8 months after establishment of PBM protocol
rate of post operative anemia (Hb<12g/dL)/ rate of post operative iron treatment
Time frame: at 2 and 8 months after establishment of PBM protocol
rate of delayed post operative anemia or iron deficiency
Time frame: at 2 and 8 months after establishment of PBM protocol
FQoR 15 on the day of hospital dischage
Time frame: at 2 and 8 months after establishment of PBM protocol
FQoR 15 at the post operative surgical visit
Time frame: at 2 and 8 months after establishment of PBM protocol
comparison of rate of anemia screening
Time frame: at 2 and 8 months after establishment of PBM protocol
comparison of iron treatment rate
Time frame: at 2 and 8 months after establishment of PBM protocol
comparison of the rate of missing datas
Time frame: at 2 and 8 months after establishment of PBM protocol
comparison of the rate of preoperative anemia
Time frame: at 2 and 8 months after establishment of PBM protocol
comparison of the rate of peri opeartive transfusion
Time frame: at 2 and 8 months after establishment of PBM protocol
comparison of the mean of FQoR-15
Time frame: at 2 and 8 months after establishment of PBM protocol
comparison of FQoR-15 means between patients with or without preoperative anemia
Time frame: at 2 and 8 months after establishment of PBM protocol
comparison of the rate of screening anemia and the rate of preoperative anemia
Time frame: at 2 and 8 months after establishment of PBM protocol
comparison of Hb level between anesthetic evaluation and pre anesthetic visit (paired T test)
Time frame: at 2 and 8 months after establishment of PBM protocol
mean difference of hemoglobin level after iron treatment
Contact information is provided by the study sponsor or research team.
University Hospital, Angers
Other Gov
Evaluation du Protocole de PBM du Service de Chirurgie gynécologique du CHU d'Angers: étude Periope 2
Acronym: PERIOPESGYNECO
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07715318
Anemia, Chronic Disease
View Trial DetailsNCT07701499
Anemia, Hematologic Diseases
Jakarta, DKI Jakarta, Indonesia
View Trial DetailsNCT07671469
Anemia, Blood Transfusion
Palo Alto, California, United States
View Trial DetailsNCT07661602
Anemia, Anemia, Hypochromic
Kathmandu, Bagmati, Nepal
View Trial Details